Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 179

CBD Blood Pressure Research and Development Cannabinoids 179

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. Junk’ cannabis ‘ill-suited for clinical trials’.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

FloridaMarijuana.net

AUGUST 15, 2018

If this mechanism is forced to be used repeatedly and often, the body does not properly heal or develop. Often, Post-Traumatic Stress Disorder, a debilitating and chronic illness, can develop. About 10 of every 100 women (or 10%) develop PTSD sometime in their lives compared with about 4 of every 100 men (or 4%).

Treatment 182

Treatment Marijuana Research and Development Therapy 182

CannaMD

MARCH 8, 2021

House Bill 1455, which seeks to “cap” THC potency, limit physician prescribing practices, and all but eliminate physician and dispensary advertising, has come under sharp criticism from patients, physicians, and industry insiders alike. 1455 – and how YOU can fight back with research-based arguments! Studies Supporting THC.

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

JULY 8, 2021

(NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. produced, THC-free 1 CBD products.

Research and Development 85

Research and Development Pets Cannabinoids eCommerce 85

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD.

DEA 51

DEA Clinical Trials THC Research and Development 51

The Cannigma

APRIL 12, 2023

The MoreBetter & CBDistillery CBN study CBN, or cannabinol , is a natural product of THC degradation; it can be found in aged, poorly stored cannabis plants and also in cannabis smoke. Like THC , CBN is a natural anti-inflammatory. What this means for CBN research These results are, in a word, impressive.

Sleep 133

Sleep Data Tincture Research and Development 133

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Medicinal Marijuana Association

AUGUST 27, 2019

Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Puff Puff Post

JULY 8, 2019

. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.

Chronic Pain 109

Chronic Pain Research and Development Clinical Trials THC 109

Puff Puff Post

JULY 8, 2019

. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. Study co-author Joanna Zeiger, MS, Ph.D.

Chronic Pain 108

Chronic Pain Research and Development Clinical Trials THC 108

Veriheal

MAY 3, 2022

A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research. Clinical Trial Sample Size.

Research and Development 98

Research and Development Clinical Trials Consumption Patients 98

Cannabis Law Report

NOVEMBER 29, 2019

Tetrahydrocannabinol (THC) is the element in cannabis that gets a person high. THC is the psychoactive compound in cannabis. But, THC has a similar chemical makeup with cannabidiol or CBD. CBD combats THC’s effects. THC alters communication functions. That’s why some people choose THC oil. THC Oil Benefits.

Oil 80

Oil THC Cannabinoids Research and Development 80

The Cannigma

DECEMBER 14, 2021

This synthetic derivative of naturally occurring delta-9-Tetrahydrocannabinol (delta-9-THC) was first reported by noted cannabis chemist Professor Roger Adams at the University of Illinois in 1940. HHC was synthesized in Adams’ laboratory as part of research to understand the active compounds in the cannabis plant.

Research and Development 116

Research and Development Clinical Trials Cannabinoids THC 116

CannaMD

MAY 25, 2021

In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. THC, CBD & THE ECS. CBD PROMOTES BONE GROWTH. In their summary, the study’s authors noted that.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

LifeCannMD

AUGUST 2, 2024

Research has indicated that cannabinoids might have antitumor properties. Cannabinoids like THC and CBD have been studied for their potential to treat both melanoma and non-melanoma skin cancers. RSO is typically made from Cannabis indica strains and contains high levels of tetrahydrocannabinol (THC).

Clinical Trials 52

Clinical Trials Cannabinoids Research and Development Concentrates 52

Veriheal

OCTOBER 13, 2020

While another study has shown that patients suffering from IBS involving predominant diarrhea, will benefit most from synthetic tetrahydrocannabinol (THC) known as dronabinol- although we recommend using extreme caution with synthetic cannabinoids. A Neuroscience Researcher Weighs in. Q: How might THC and CBD be able to modulate it? “We

Digestion 124

Digestion Treatment Conditions Research and Development 124

Cannabis Law Report

AUGUST 2, 2021

OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinical trial on neuropathic and post-operative pain. TEL AVIV, Israel , Aug.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. Visit [link].

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. Highlights: According to a U.S. The patent.

THC 64

THC CBD Cannabinoids Research and Development 64

MMJ Recs

JULY 5, 2024

The use of THC (Tetrahydrocannabinol) has surged dramatically over the years with an increasing interest in the potential health benefits for medical marijuana patients. From pain management to mental health, THC is being explored for its therapeutic properties at an unprecedented rate. What is THC?

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Terpenes interact with both cannabidiol and THC and change the effects that either drug has on the body. Preliminary Research on CBD Oil. CBD is the most abundant active ingredient within the CBD oil.

CBD 52

CBD Clinical Trials Research and Development Oil 52

Puff Puff Post

JANUARY 13, 2020

Now that retailers broadly sell CBD oil, it offers a number of challenges and opportunities to medical researchers. Terpenes interact with both cannabidiol and THC and change the effects that either drug has on the body. Preliminary Research on CBD Oil. CBD is the most abundant active ingredient within the CBD oil.

CBD 52

CBD Clinical Trials Research and Development Oil 52

The Cannigma

FEBRUARY 2, 2021

However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. Still, research is ongoing. Patients can also access CBD products without a prescription through local pharmacies. “Our

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 119

Research and Development Education Agriculture Patients 119

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. At this point, it seems seizure disorders respond best to a range of 27:1 to 15:1 CBD: THC full spectrum cannabis oil.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

CannaMD

MARCH 8, 2020

Researchers summarized five key points from the 2020 review : * We estimate that more than 2 million U.S. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Instead, the study can be seen as a starting point for discussion and further study. Arrhythmia.

Patients 104

Patients Marijuana Research and Development Clinical Trials 104

Cannabis Law Report

JUNE 17, 2021

Brains unparalleled expertise and manufacturing capabilities in the CBD space combined with DSM’s unique scientific and marketing capabilities in the pharmaceutical sector make this the ideal partnership to help pharmaceutical players realizing the potential of CBD’s for early stage drug development.’’. ABOUT BRAINS BIOCEUTICAL CORP.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Events 105

MMJ Recs

JULY 9, 2024

Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures. THC is primarily responsible for the psychoactive effects associated with marijuana, while CBD is known for its therapeutic properties without causing a “high.”

Marijuana 111

Marijuana Treatment Cannabinoids Patients 111

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Major research hospitals such as Montefiore in New York now use cannabis for treating cancer and HIV, as well as make new studies.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary psychoactive compound in cannabis, responsible for the “high” or euphoric feeling associated with marijuana use.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

The Cannigma

JUNE 23, 2022

CBGA is naturally produced by the cannabis plant, and is the precursor to all of the phyto-, or plant-related cannabinoids like THC, CBD, CBN and CBG. Often CBGA is presumed to interact with CB1 and CB2 receptors, more similar to THC and or CBG, but emerging science suggests this is likely not the case. What does CBGA do?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

Greencamp

FEBRUARY 17, 2019

The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. Crohn’s Disease and Marijuana: Efficacy, Research and Dosing. In fact, the risk of developing IBS increases after a gastrointestinal infection for about 10%. Research on cannabis and IBS.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

CannaMD

JUNE 2, 2021

A quarter of all users did not know the strain or THC/CBD content of the product they were using. In their concluding remarks, the study authors noted that “the lack of formal guidance or research evidence about cannabis for Parkinson’s treatment may in part underlie inconsistencies in both use and reported effectiveness.”

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Veriheal

APRIL 18, 2022

According to the 2022 study published in the journal Drug and Alcohol Dependence, researchers found that smoking cannabis accelerates the biological aging process. The researchers decided to make use of a tool known as “ epigenetic clocks” in order to understand whether smoking cannabis accelerates or decreases the aging process.

Research and Development 98

Research and Development Clinical Trials Conditions Cannabis 98